Concepedia

Publication | Open Access

ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer

25

Citations

33

References

2020

Year

Abstract

The correlation between ROS1-fusion and PD-L1 overexpression suggested that PD-L1/PD-1 blockade could be the second-line treatment option for the Crizotinib-resistant NSCLC with <i>ROS1</i> rearrangement.

References

YearCitations

Page 1